Previous studies have suggested that high concentrations of bradykinin and increased B2R activity can be found in the cortex of Alzheimer’s disease patients, indicating the participation of this receptor signaling pathway in inflammation-related processes [47]. Here, BDKRB2 is linked to early-onset autosomal dominant Alzheimer disease.